Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5α-reductase inhibitor
Sutkowski, Debra M., Audia, James E., Goode, Robin L., Hsiao, Kenneth C., Leibovitch, Ilan Y., McNulty, Ann M., Neubauer, Blake LeeVolume:
29
Year:
1996
Language:
english
Pages:
5
Journal:
The Prostate
DOI:
10.1002/(sici)1097-0045(1996)6+3.0.co;2-p
File:
PDF, 428 KB
english, 1996